Test Your SOHO Knowledge!
A quiz based on the latest lung cancer news and studies from SOHO.
Read More
Tibsovo – Quiz Display Banners Conference – 25433
SOHO 2022 eBook
SOHO 2022 Conference Report.indd
Read More
For Refractory/Relapsed AML, Total Therapy Proves Superior to Standard Care
For patients with refractory/relapsed acute myeloid leukemia (AML), total therapy, as compared...
Read More
Survival Benefit With IVO-AZA Combo for Acute Myeloid Leukemia
For patients with newly diagnosed, IDH1-mutated acute myeloid leukemia (AML), ivosidenib (IVO)...
Read More
In Hematologic Cancer, Orca-T Reduced GVHD
In patients with hematologic malignancies, the use of Orca-T, a high-precision cell therapy, led...
Read More
For Patients With AML, IVO/VEN/AZA Combo Bolsters Survival
In patients with acute myeloid leukemia (AML) across several study cohorts, ivosidenib (IVO) +...
Read More
SOHO 2022 COVID-19 Plan
Physical Distancing Physical distancing will be encouraged in all gathering areas. Since attendees...
Read More
SOHO 2022 Speakers
SOHO 2022 annual meeting boasts internationally recognized experts in the field of hematologic...
Read More
Why Attend SOHO 2022
September 28-October 1, 2022 is the tenth annual Society of Hematologic Oncology (SOHO) meeting....
Read More
Acute Myeloid Leukemia Remission Rates Based on Body Mass Index
In many research studies, the influence of body mass index (BMI) on the prognosis of individuals...
Read More
Newly Diagnosed Acute Myeloid Leukemia With an IDH1 Mutation: Ivosidenib + Azacitidine versus Placebo + Azacitidine
Isocitrate dehydrogenase 1 (IDH1) mutations are oncogenic factors in acute myeloid leukemia (AML),...
Read More
Oncohematology Patients Admitted to the Intensive Care Unit
Oncohematology (OH) patients are supported by the intensive care unit (ICU). Admission of OH...
Read More
Hematologic Patients with Bone Marrow Aspiration: An Observational Study of Pain and Anxiety
Bone marrow aspiration is a key method for identifying hematologic malignancies, monitoring...
Read More
AML with TP53 mutations and MDS with TP53 mutations share similarities
About 10% of individuals with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) have...
Read More